About Us
Our Mission
We are a clinical stage biotech company committed to protecting patients’ brain health and changing outcomes for a broad range of neurodegenerative diseases through best-in-class diagnostic tools and novel therapies.
Our name, APRINOIA, merges the Latin word for sunlight, “apricum,” with the Greek suffix for the mind, “noia.” Our name reflects our mission—to shed light on ways to better diagnose and treat these dreaded neurodegenerative disorders with a vision that these novel diagnostic tools together with targeted therapies will offer a better future for our patients.
Our Team
Our Partners
We have aligned with renowned organizations and elite research institutions to bring precision medicine to neuroscience and push boundaries in the treatment of neurodegenerative diseases. We will continue to expand our partnerships to further develop therapeutic assets through late-phase clinical studies and commercialization.
Research and Development Partners
Finance Partners
